This data is confirmed by Kwon et al. [37] in a study of 42 early-stage laryngeal cancers, which notes that GLUT1 was not found to exert any influence on residual tumor or survival after radiotherapy. This evidence concerns the gene SLC2A1 and laryngeal carcinoma.